Safety and efficacy of cell-free and concentrated ascites reinfusion therapy (CART) in refractory ascites: Post-marketing surveillance results

We performed post-marketing surveillance to evaluate the safety and efficacy of cell-free and concentrated ascites reinfusion therapy (CART). In total, 356 CART sessions in 147 patients at 22 centers were performed. The most common primary disease was cancer (128 cases, 300 sessions). Mean amount of...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:PLoS One
Hoofdauteurs: Hanafusa, Norio, Isoai, Ayako, Ishihara, Tomoaki, Inoue, Tetsuya, Ishitani, Ken, Utsugisawa, Taiju, Yamaka, Toshihiko, Ito, Tetsuya, Sugiyama, Hiroshi, Arakawa, Atsushi, Yamada, Yosuke, Itano, Yasuo, Onodera, Hirokazu, Kobayashi, Ryosuke, Torii, Naoko, Numata, Toyoko, Kashiwabara, Taihei, Matsuno, Yoshihiro, Kato, Michio
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Public Library of Science 2017
Onderwerpen:
Research Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5433707/
https://ncbi.nlm.nih.gov/pubmed/28510606
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0177303
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items